TYGACIL

This brand name is authorized in Austria, Brazil, Canada, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug TYGACIL contains one active pharmaceutical ingredient (API):

1 Tigecycline UNII 70JE2N95KR - TIGECYCLINE

Tigecycline, a glycylcycline antibiotic, inhibits protein translation in bacteria by binding to the 30S ribosomal subunit and blocking entry of amino-acyl tRNA molecules into the A site of the ribosome. This prevents incorporation of amino acid residues into elongating peptide chains. Read about Tigecycline

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
TYGACIIL Powder for solution for infusion	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J01AA12	Tigecycline	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01A Tetracyclines → J01AA Tetracyclines
Discover more medicines within J01AA12

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 522710001153315
Country: CA	Health Products and Food Branch	Identifier(s): 02285401
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 1858-MEE-0316
Country: EE	Ravimiamet	Identifier(s): 1243695
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 06336001
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 024024
Country: FR	Base de données publique des médicaments	Identifier(s): 69265912
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 103211
Country: HK	Department of Health Drug Office	Identifier(s): 54821
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 6981
Country: IT	Agenzia del Farmaco	Identifier(s): 037046012
Country: JP	医薬品医療機器総合機構	Identifier(s): 6129400F1020
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1031483
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 492M2005
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 80500
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 12190
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100052956
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W64909001
Country: SG	Health Sciences Authority	Identifier(s): 13282P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 8013161H, 8063141H
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8681308791009
Country: US	FDA, National Drug Code	Identifier(s): 0008-4990, 0008-4994
Country: ZA	Health Products Regulatory Authority	Identifier(s): A40/20.1.1/0230